In line with this, the analyses of a primary BrCa tissues array demonstrated a trend of increase in the number of N-Cadherin positive cells in ER positive tumours, known to be less malignant, suggesting that N-Cadherin expression could be associated with less aggressive human primary tumours. The gene discussed is CDH2; the disease is neoplasm.